DECODING HCPS’ EVOLVING RELATIONSHIPS WITH PHARMA, PEERS, AND THE PATIENT

By: Steve Madden, Editor-in-Chief, MM+M

Excerpted from MM+M:

The impact of coronavirus is felt across every facet of society, but healthcare in particular is acutely impacted by the pandemic. Pharmaceutical representatives have been unable to physically meet with healthcare providers since early 2020. In order to understand the changing role of the pharmaceutical rep—and the state of medicine at large—Razorfish Health launched an exhaustive survey to HCPs across therapeutic areas. As healthcare marketers seek to reach HCPs in both their “white coat” and “blue jean” moments, RFH sought to understand the key themes and struggles of healthcare providers in 2021.

Kara Dugan, President, Razorfish Health sat down with Stephen Madden, Editor-in-Chief, MM&M, to discuss the highly anticipated results of the survey. Together they unpack the highlights and a comprehensive report will be released in the form of an e-book later this Spring.

Check out the interview on MM&M.

About Razorfish Health:

Fueling the Practice of Modern Medicine

Razorfish Health (RFH) is a full-service creative agency with deep roots and expertise in healthcare providers (HCPs) and the patients that they serve. As the first digital healthcare agency, we are passionately on the forefront of fueling the practice of modern medicine, helping to shape how it is practiced today and how it will be taught for tomorrow. Our driving purpose is to develop inventive, data-driven communications that help HCPs and patients make better connections for better outcomes.

To learn more about Razorfish Health, visit the website and for the latest news and updates, follow Razorfish Health on Instagram, LinkedIn, Twitter, and Facebook.